  Burkholderia is an important genus encompassing a variety of species,
including pathogenic strains as well as strains that promote plant growth. We
have carried out a global strategy, which combined two complementary
approaches. The first one is genome guided with deep analysis of genome
sequences and the second one is assay guided with experiments to support the
predictions obtained in silico. This efficient screening for new secondary
metabolites, performed on 48 gapless genomes of Burkholderia species, revealed
a total of 161 clusters containing nonribosomal peptide synthetases (NRPSs),
with the potential to synthesize at least 11 novel products. Most of them are
siderophores or lipopeptides, two classes of products with potential
application in biocontrol. The strategy led to the identification, for the
first time, of the cluster for cepaciachelin biosynthesis in the genome of
Burkholderia ambifaria AMMD and a cluster corresponding to a new
malleobactin-like siderophore, called phymabactin, was identified in
Burkholderia phymatum STM815 genome. In both cases, the siderophore was
produced when the strain was grown in iron-limited conditions. Elsewhere, the
cluster for the antifungal burkholdin was detected in the genome of B.
ambifaria AMMD and also Burkholderia sp. KJ006. Burkholderia pseudomallei
strains harbor the genetic potential to produce a novel lipopeptide called
burkhomycin, containing a peptidyl moiety of 12 monomers. A mixture of
lipopeptides produced by Burkholderia rhizoxinica lowered the surface tension
of the supernatant from 70 to 27 mN/m. The production of nonribosomal secondary
metabolites seems related to the three phylogenetic groups obtained from 16S
rRNA sequences. Moreover, the genome-mining approach gave new insights into the
nonribosomal synthesis exemplified by the identification of dual C/E domains in
lipopeptide NRPSs, up to now essentially found in Pseudomonas strains.
